Nov 4, 2025
According to Gulf Business, Health Holding Company (HHC) signed 13 agreements valued at approximately SAR660 million during this year’s Global Health Exhibition in Riyadh. Dr. Saad Albattal, chief medical officer for chronic disease at HHC, detailed the company’s latest initiatives and strategic direction at the event.
“This year at the Global Health Exhibition 2025, which is in its eighth edition, we launched four initiatives,” said Dr. Albattal. “The first one is the Diabetic Command Centre. The second is the Lifestyle Restriction Programme. The third is a Programme of Excellence in Robotic Surgery. And the fourth is the Brain Site, which is advanced surgery for neuroscience and brain surgery.”
Each initiative addresses a national priority ranging from chronic disease management to medical specialisation and advanced surgical care. Dr. Albattal highlighted that success depends on community engagement and proactive care.
“I believe the key success in that is reaching out to the people, managing their problems on a daily basis and being proactive in terms of community screening; taking care of their chronic disease, and through cancer screening,” he explained. “Early screening of all of these diseases will prolong the longevity of the populations and improve the quality of life that people are living.”
The 13 agreements signed at the exhibition involved multiple partners. “Agreements [were signed] in different aspects with Alinma Bank, Microsoft, Roche Arabia, American Heart Association for training, and with national research centers and other partners.” Dr. Albattal stated that “The aim of all of these agreements is pushing the advancement of healthcare services and pushing technology and healthcare practice.”
Dr. Albattal emphasized that Health Holding’s transformation includes reframing citizens and residents as beneficiaries who participate in their own health management. “Our patients are part of the decision making. And they are not only patients, they are a beneficiary,” he said.
This shift toward prevention is central to HHC’s strategy. “Our main aim is maintaining health before being reactive and curing the disease,” he explained. “Our duty to our beneficiaries is to educate them, empower them, be accessible to them in different mediums, either virtually or physically, and provide the care based on the best standard.”
Saudi Arabia’s healthcare transformation under Vision 2030 is driven by a shift from volume to value-based care. For Dr. Albattal, this principle lies “at the heart of health transformations.”
“We are committed not to the volume, but for the quality, taking care of medical decisions, patient experience and the cost of all of these services,” he said. “Value-based healthcare on the long run will save money, provide better quality of life to our beneficiaries, and will reflect positively in terms of cost.”
Source: IndexBox Market Intelligence Platform
link
